ScholarLens Back to search
1996•Kitakantou igaku/Kitakantō IgakuOpen access

INVESTIGATION OF PROSTATE-SPECIFIC ANTIGEN IN PROSTATE CANCER. DETECTION OF EARLY PROSTATE CANCER.

K Saito, Hiroshi Okazaki, Toshiyuki Nakamura, Nobuo Kato

Open full text 0 citations

Abstract

We investigated of PSA in 57 patients who underwent the prostate biopsy in our hospital during 1994. Serum PSA level were determined with a Markit-M kit. Sensitivity and specificity for prostate cancer at the current standard value of PSA of 3.6 ng/ml (with our PSA kit) were 74.2% and 61.5%, respectively. There were six cases of prostate cancer with PSA values in the 1.5-3.6 ng/ml ceange 6, and 5 of these cases were stage B. Judging from these results, it seems quite necessary to perform prostate biopsy or intense management even if the PSA value is 1. 5-3.6 ng/ml.

Open-access reader

About this research paper

What this paper is about

We investigated of PSA in 57 patients who underwent the prostate biopsy in our hospital during 1994. Serum PSA level were determined with a Markit-M kit. Sensitivity and specificity for prostate cancer at the current standard value of PSA of 3.6 ng/ml (with our PSA kit) were 74.2% and 61.5%, respectively. There were six cases of prostate cancer with PSA values in the 1.5-3.6 ng/ml ceange 6, and 5 of these cases were stage B. Judging from these results, it seems quite necessary to perform prostate biopsy or intense management even if the PSA value is 1. 5-3.6 ng/ml.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

We investigated of PSA in 57 patients who underwent the prostate biopsy in our hospital during 1994. Serum PSA level were determined with a Markit-M kit. Sensitivity and specificity for prostate cancer at the current standard value of PSA of 3.6 ng/ml (with our PSA kit) were 74.2% and 61.5%, respectively. There were six cases of prostate cancer with PSA values in the 1.5-3.6 ng/ml ceange 6, and 5 of these cases were stage B. Judging from these results, it seems quite necessary to perform prostate biopsy or intense management even if the PSA value is 1. 5-3.6 ng/ml.

Key concepts: Prostate cancer, Medicine, Urology, Prostate, Prostate-specific antigen, Prostate biopsy, Biopsy, Management of prostate cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
INVESTIGATION OF PROSTATE-SPECIFIC ANTIGEN IN PROSTATE CANCER. DETECTION OF EARLY PROSTATE CANCER. — Research Paper | ScholarLens